Experimental and Clinical Endocrinology & Diabetes, Table of Contents Exp Clin Endocrinol Diabetes 2019; 127(S 01): S1-S7DOI: 10.1055/a-1018-9078 German Diabetes Association: Clinical Practice Guidelines © Georg Thieme Verlag KG Stuttgart · New YorkDefinition, Classification and Diagnosis of Diabetes Mellitus[*] Authors Author Affiliations Astrid Petersmann 1 Institute for Clinical Chemistry and Laboratory Medicine, University Medicine, Greifswald, Germany 2 Institute for Clinical Chemistry, University Medicine, Göttingen, Germany Dirk Müller-Wieland 3 Medical Clinic I, RWTH Aachen University, Germany Ulrich A. Müller 4 Clinic for Internal Medicine III, University Hospital Jena, Germany Rüdiger Landgraf 5 German Diabetes Foundation (DDS), Düsseldorf, Germany Matthias Nauck 1 Institute for Clinical Chemistry and Laboratory Medicine, University Medicine, Greifswald, Germany 6 DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, University Medicine, Greifswald, Germany, Germany Guido Freckmann 7 Institute for Diabetes Technology, Forschungs- und Entwicklungsgesellschaft mbH at the University of Ulm, Germany Lutz Heinemann 8 Science-Consulting in Diabetes GmbH (Science & Co), Neuss, Germany Erwin Schleicher 9 Clinical Chemistry and Pathobiochemistry – Central Laboratory, University Hospital Tübingen, Germany 10 German Centre for Diabetes Research (DZD), Munich-Neuherberg, Germany Recommend Article Abstract Full Text References References 1 Deutsche Diabetes Gesellschaft und Deutsche Gesellschaft für Gynäkologie und Geburtshilfe, (Hrsg.) S3-Leitlinie Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge. AWMF-Registernummer: 057-008. 2018; 2. Auflage https://www.awmf.org/uploads/tx_szleitlinien/ 057-008l_S3_Gestationsdiabetes-mellitus-GDM-Diagnostik-Therapie- Nachsorge_2019-06.pdf Stand: 14.08.2019 2 Buzzetti R, Zampetti S, Maddaloni E. et al. Adult-onset autoimmune diabetes: Current knowledge and implications for management. Nat Rev Endocrinol 2017; 13: 674-686 3 Badenhoop K. MODY und andere monogenetische Diabetesformen. Diabetologe 2017; 13: 453-463 4 Bojunga J, Schlereth F. Type 3c diabetes mellitus-prevalence, diagnosis, special aspects of treatment. Diabetologe 2018; 14: 269-277 5 „Richtlinie der Bundesärztekammer zur Qualitätssicherung laboratori- umsmedizinischer Untersuchungen“. Dtsch Arztebl International. 2013 110. 1822 6 Masuch A. et al. Preventing misdiagnosis of diabetes in the elderly: Age- dependent HbA1c reference intervals derived from two population-ba- sed study cohorts. BMC Endocr Disord 2019; 19: 20 7 Ziegler AG. et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 2013; 309: 2473-2479 8 Kufeldt J. et al. Prevalence and distribution of diabetes mellitus in a maximum care hospital: Urgent need for HbA1c-screening. Exp Clin Endocrinol Diabetes 2018; 126: 123-129 9 Ahlqvist E. et al. Novel subgroups of adult-onset diabetes and their association with outcomes: A data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol 2018; 6: 361-369 10 Zaharia OP. German Diabetes Study Group et al Risk of diabetes-asso- ciated diseases in subgroups of patients with recent-onset diabetes: A 5-year follow-up study. Lancet Diabetes Endocrinol. 2019 11 Ziegler AG. et al. Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: The GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol. BMJ Open 2019; 9 (06) e028578 .
